Streptococcal Group B Infection Latest Advances

Antimicrobial resistance patterns and polymicrobial co-detection characteristics of vaginal Group B Streptococcus in pregnant women: a retrospective study.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: June 22, 2026

The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus.

Journal: Infection and immunity

Published: June 15, 2026

The novel prophage lysin Lys1459 exhibits broad-spectrum antibacterial activity via triple-binding domain.

Journal: Applied and environmental microbiology

Published: June 11, 2026

Data-Independent Acquisition-Based Quantitative Proteomics, Nontargeted Metabolomics, and Protein-Ligand Interaction Reveal the Mechanism of Baicalin Inhibiting β-hemolytic/cytolytic Activities of Streptococcus agalactiae.

Journal: Journal of agricultural and food chemistry

Published: June 05, 2026

A cross-strain CRISPRi sgRNA library for Streptococcus agalactiae.

Journal: Microbiology resource announcements

Published: June 04, 2026

The bacterial cell membrane acts as a dynamic heme reservoir during group B Streptococcus bloodstream infection.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

First case of penicillin-resistant Streptococcus agalactiae (group B Streptococcus) isolated from an adult patient in Italy, February 2026.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: May 22, 2026

In Vivo Efficacy of Bacteriophage Therapy Against Streptococcus agalactiae in Nile Tilapia (Oreochromis niloticus): Delivery Route and a Dose-Dependent Effect of Survival, Immune Responses, and Tissue Recovery.

Journal: PHAGE (New Rochelle, N.Y.)

Published: May 18, 2026

Optimal screening strategies, colonization rates, and antimicrobial resistance within a newly implemented organized group B Streptococcus screening program in Slovenia.

Journal: Diagnostic microbiology and infectious disease

Published: May 04, 2026

RodA promotes intestinal colonization by group B Streptococcus.

Journal: Infection and immunity

Published: April 30, 2026

Akkermansia muciniphila impacts group B Streptococcus vaginal colonization.

Journal: mBio

Published: April 27, 2026

Oral immunization of Nile tilapia with Chlorella-bioencapsulated multi-epitope fusion antigen effectively protects against Streptococcus agalactiae infection.

Journal: Fish & shellfish immunology

Published: April 27, 2026

Streptococcal Group B Infection Latest Advances

Find the Latest Research About Streptococcal Group B Infection

Antimicrobial resistance patterns and polymicrobial co-detection characteristics of vaginal Group B Streptococcus in pregnant women: a retrospective study.

Antimicrobial resistance patterns and polymicrobial co-detection characteristics of vaginal Group B Streptococcus in pregnant women: a retrospective study.

The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus.

The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus.

The novel prophage lysin Lys1459 exhibits broad-spectrum antibacterial activity via triple-binding domain.

The novel prophage lysin Lys1459 exhibits broad-spectrum antibacterial activity via triple-binding domain.

Data-Independent Acquisition-Based Quantitative Proteomics, Nontargeted Metabolomics, and Protein-Ligand Interaction Reveal the Mechanism of Baicalin Inhibiting β-hemolytic/cytolytic Activities of Streptococcus agalactiae.

Data-Independent Acquisition-Based Quantitative Proteomics, Nontargeted Metabolomics, and Protein-Ligand Interaction Reveal the Mechanism of Baicalin Inhibiting β-hemolytic/cytolytic Activities of Streptococcus agalactiae.

A cross-strain CRISPRi sgRNA library for Streptococcus agalactiae.

A cross-strain CRISPRi sgRNA library for Streptococcus agalactiae.

The bacterial cell membrane acts as a dynamic heme reservoir during group B Streptococcus bloodstream infection.

The bacterial cell membrane acts as a dynamic heme reservoir during group B Streptococcus bloodstream infection.

First case of penicillin-resistant Streptococcus agalactiae (group B Streptococcus) isolated from an adult patient in Italy, February 2026.

First case of penicillin-resistant Streptococcus agalactiae (group B Streptococcus) isolated from an adult patient in Italy, February 2026.

In Vivo Efficacy of Bacteriophage Therapy Against Streptococcus agalactiae in Nile Tilapia (Oreochromis niloticus): Delivery Route and a Dose-Dependent Effect of Survival, Immune Responses, and Tissue Recovery.

In Vivo Efficacy of Bacteriophage Therapy Against Streptococcus agalactiae in Nile Tilapia (Oreochromis niloticus): Delivery Route and a Dose-Dependent Effect of Survival, Immune Responses, and Tissue Recovery.

Optimal screening strategies, colonization rates, and antimicrobial resistance within a newly implemented organized group B Streptococcus screening program in Slovenia.

Optimal screening strategies, colonization rates, and antimicrobial resistance within a newly implemented organized group B Streptococcus screening program in Slovenia.

RodA promotes intestinal colonization by group B Streptococcus.

RodA promotes intestinal colonization by group B Streptococcus.

Akkermansia muciniphila impacts group B Streptococcus vaginal colonization.

Akkermansia muciniphila impacts group B Streptococcus vaginal colonization.

Oral immunization of Nile tilapia with Chlorella-bioencapsulated multi-epitope fusion antigen effectively protects against Streptococcus agalactiae infection.

Oral immunization of Nile tilapia with Chlorella-bioencapsulated multi-epitope fusion antigen effectively protects against Streptococcus agalactiae infection.